Petauri™ completes acquisition of Brightly Network's medical communications agencies
Acquiring Company
Petauri
Acquired Company
Brightly Network
Description
Petauri, a leading purpose-built pharmaceutical services platform, has announced the acquisition of four US-based firms: Bluprint Oncology, Cogency, Verascity, and Blendworks, from the Brightly Network. This acquisition further expands Petauri's capabilities and expertise in medical communications, specializing in oncology, hematology, and rare diseases across medical and commercial strategy, engagement, and education.
Quick answer
Petauri is acquiring Brightly Network, announced August 14, 2024. Petauri is based in Nashville, Tennessee, United States.
- How much did Petauri pay for Brightly Network?
- The deal value was not disclosed.
- What does Petauri do?
- Petauri™ is a purpose-built pharmaceutical services organization.
- Where are Petauri and Brightly Network based?
- Petauri is based in Nashville, Tennessee, United States. Brightly Network is based in Nashville, Tennessee, United States.
- Who are the decision-makers at Petauri?
- Fundz holds 2 contacts at Petauri. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Flat Medical strengthens market leadership with acquisition of InjeQ assets, including FDA-Designated Breakthrough Device IQ-Tip® (September 25, 2024)
- KARL STORZ completes acquisition of Asensus Surgical, Inc. to strengthen its position in robotic and digital surgical market (August 22, 2024)
- Leapcure Acquires Honeybee Trials: Enhancing Patient Engagement and Research Site Solutions (August 13, 2024)
- GE HealthCare to acquire clinical artificial intelligence business from Intelligent Ultrasound Group PLC (July 18, 2024)
- AA Medical completes acquisition of Surgical Product Solutions, forming strategic partnership (July 11, 2024)
- Pinnacle Clinical Research acquires Jubilee Clinical Research to strengthen expertise in metabolic and cardiovascular diseases (September 27, 2024)
Who to call at Petauri, and when
When Petauri changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Petauri raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Petauri, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Petauri. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Petauri makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Brightly Network?
Brightly Network was acquired by Petauri, based in Nashville. The deal was reported on August 14, 2024. Petauri™ is a purpose-built pharmaceutical services organization. Petauri is privately held and operates in Biotechnology.
When did Petauri acquire Brightly Network?
Petauri's acquisition of Brightly Network was reported on August 14, 2024. Petauri, a leading purpose-built pharmaceutical services platform, has announced the acquisition of four US-based firms: Bluprint Oncology, Cogency, Verascity, and Blendworks, from the Brightly Network. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Brightly Network do?
We are a network of healthcare communicators. We are forward thinkers, creating bright solutions and igniting innovation. It is privately held, operating in Health Care, and is based in Nashville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.